These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 3618617)
1. Cost analysis of mixing clindamycin and aminoglycosides. Abel SR; Olson SM Am J Hosp Pharm; 1987 Jun; 44(6):1385-7. PubMed ID: 3618617 [TBL] [Abstract][Full Text] [Related]
2. Personnel time and preparation costs for compounded versus premixed intravenous admixtures in three community hospitals. Kirschenbaum BE; Cacace L; Anderson RJ; Ackerman LA Am J Hosp Pharm; 1988 Mar; 45(3):605-8. PubMed ID: 3369464 [TBL] [Abstract][Full Text] [Related]
3. Stability and cost analysis of clindamycin-gentamicin admixtures given every eight hours. Mansur JM; Abramowitz PW; Lerner SA; Smith RB; Townsend RJ Am J Hosp Pharm; 1985 Feb; 42(2):332-5. PubMed ID: 3976680 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of gentamicin premixed admixtures: cost and clinical utility. Zarowitz BJ; Owen H; Popovich J; Pancorbo S Hosp Pharm; 1987 Mar; 22(3):257-60. PubMed ID: 10311980 [TBL] [Abstract][Full Text] [Related]
5. Justification of a pharmacy intravenous admixture service in an Australian hospital. Plumridge RJ; Maher M Am J Hosp Pharm; 1993 Mar; 50(3):463-6. PubMed ID: 8442462 [TBL] [Abstract][Full Text] [Related]
6. Variable cost per dose of preparing and administering small-volume cephalosporin admixtures. Veterans Administration Pharmacy Service Study Group. Am J Hosp Pharm; 1984 Dec; 41(12):2624-34. PubMed ID: 6517086 [TBL] [Abstract][Full Text] [Related]
7. Effectiveness of an antibiotic cost containment measure. Jung B; Andrews JD Can J Hosp Pharm; 1990 Jun; 43(3):116-22. PubMed ID: 10105649 [TBL] [Abstract][Full Text] [Related]
9. Cost analysis of an aminoglycoside pharmacokinetic dosing program. Schloemer JH; Zagozen JJ Am J Hosp Pharm; 1984 Nov; 41(11):2347-51. PubMed ID: 6507436 [TBL] [Abstract][Full Text] [Related]
10. Cost of individualizing aminoglycoside dosage regimens. Bootman JL; Zaske DE; Wertheimer AI; Rowland C Am J Hosp Pharm; 1979 Mar; 36(3):368-70. PubMed ID: 420232 [TBL] [Abstract][Full Text] [Related]
11. Financial impact of an aminoglycoside substitution program. Andrews JD; Stad K Can J Hosp Pharm; 1987 Feb; 40(1):23-6. PubMed ID: 10281256 [TBL] [Abstract][Full Text] [Related]
12. Personnel costs and preparation time in a centralized intravenous admixture program. Ryan DM; Daniels CE; Somani SM Am J Hosp Pharm; 1986 May; 43(5):1222-5. PubMed ID: 3087164 [TBL] [Abstract][Full Text] [Related]
13. Monitoring waste in an intravenous admixture program. Mitchell SR Am J Hosp Pharm; 1987 Jan; 44(1):106-11. PubMed ID: 3826083 [TBL] [Abstract][Full Text] [Related]
14. The effect of pharmacy intervention on aminoglycoside costs. Tsuyuki RT; Nakagawa RS Can J Hosp Pharm; 1987 Apr; 40(2):51-6. PubMed ID: 10282090 [TBL] [Abstract][Full Text] [Related]
15. Cost savings with a new combination clindamycin-gentamicin admixture policy. Rogers RC; Lee MD; McNeeley SG; Encalade JH; Ryan MK Hosp Pharm; 1987 Jul; 22(7):698-700, 718. PubMed ID: 10282687 [TBL] [Abstract][Full Text] [Related]
16. Cost-benefit analysis of an aminoglycoside monitoring service. Kimelblatt BJ; Bradbury K; Chodoff L; Aggour T; Mehl B Am J Hosp Pharm; 1986 May; 43(5):1205-9. PubMed ID: 3087162 [TBL] [Abstract][Full Text] [Related]
17. [Financial assessment of device for the preparation of intravenous mixtures in hospital pharmacy]. Casado Collado A; Luengo Pascual L; Herdman M; Bonafont Pujol X; Clemente Bautista S; Jódar Masanés R; Napal Lecumberri V; Serrano Padilla G Farm Hosp; 2004; 28(4):243-50. PubMed ID: 15369434 [TBL] [Abstract][Full Text] [Related]
18. Comparison of seven methods of preparing and administering small-volume injections. Smith CF; Amen RJ Am J Hosp Pharm; 1988 Sep; 45(9):1896-901. PubMed ID: 3228122 [TBL] [Abstract][Full Text] [Related]
19. Waste of i.v. admixtures in the ADD-Vantage system and a traditional minibag system. Billeter M; Nowak MM; Rapp RP; Hunt ML Am J Hosp Pharm; 1990 Jul; 47(7):1598-600. PubMed ID: 2368755 [No Abstract] [Full Text] [Related]
20. Economics of providing antineoplastic drugs in a manufacturer-mixed bulk package. Kleinberg ML; Duafala ME Am J Hosp Pharm; 1988 Jan; 45(1):109-15. PubMed ID: 3348222 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]